Treatment of gastroparesis: A multidisciplinary clinical review

Neurogastroenterology and Motility

Volumn 18, Issue 4, 2006, Pages 263-283

  Abell, T L ^a   Bernstein, R K ^b   Cutts, T ^c   Farrugia, G ^d   Forster, J ^e   Hasler, W L ^f   Mccallum, R W ^e   Olden, K W ^g   Parkman, H P ^h   Parrish, C R ⁱ   Pasricha, P J ^j   Prather, C M ^k   Soffer, E E ^l   Twillman, R ^e   Vinik, A I ^m  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b Diabetes Research Center   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^g UNIVERSITY OF SOUTH ALABAMA   (United States)

^h TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^j UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^k SAINT LOUIS UNIVERSITY   (United States)

^l CEDARS SINAI MEDICAL CENTER   (United States)

^m EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

more..

Author keywords

Antiemetic agents; Botulinum toxin; Gastric emptying; Gastroparesis; Prokinetic agents

Indexed keywords

ALEMCINAL; AZITHROMYCIN; BETHANECHOL; CISAPRIDE; CLARITHROMYCIN; DESIPRAMINE; DEXLOXIGLUMIDE; DOLASETRON MESILATE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; GHRELIN; GRANISETRON; ITOPRIDE; LOXIGLUMIDE; METOCLOPRAMIDE; MITEMCINAL; MOSAPRIDE CITRATE; NEOSTIGMINE; NIZATIDINE; ONDANSETRON; PHYSOSTIGMINE; PROCHLORPERAZINE; PROKINETIC AGENT; RENZAPRIDE; TEGASEROD; THIETHYLPERAZINE; TRIMETHOBENZAMIDE; TROPISETRON; UNINDEXED DRUG;

ABDOMINAL PAIN; BREAST TENDERNESS; CLINICAL RESEARCH; CLINICAL TRIAL; DIABETES MELLITUS; DIAPHORESIS; DIET THERAPY; DISEASE SEVERITY; DROWSINESS; DYSTONIA; ELECTROSTIMULATION; ENDOSCOPIC THERAPY; ENTERIC FEEDING; FATIGUE; FLUSHING; GALACTORRHEA; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERPROLACTINEMIA; IRRITABILITY; MENSTRUAL IRREGULARITY; NAUSEA; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PARKINSONISM; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SIDE EFFECT; STOMACH EMPTYING; STOMACH PARESIS; SYMPTOM; TARDIVE DYSKINESIA; TREATMENT OUTCOME; VOMITING;

CONSENSUS DEVELOPMENT CONFERENCES; GASTROPARESIS; GUIDELINES; HUMANS;

EID: 33645036517     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2006.00760.x     Document Type: Review

References (167)

1. Parkman HP Hasler WL Fisher RS American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis Gastroenterology 2004 127 1592 622
2. Soykan I Sivri B Sarosiek I Kierran B McCallum RW Demography, clinical characteristics, psychological profiles, treatment and long-term follow-up of patients with gastroparesis Dig Dis Sci 1998 43 2398 404
3. Revicki DA Rentz AM Dubois D et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms Qual Life Res 2004 13 833 44
4. Farup CE Williams GR Leidy NK Helbers L Murray M Quigley EMM Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis Diabetes Care 1998 21 1699 706
5. Hoogerwerf WA Pasricha PJ Kalloo AN Schuster MM Pain: the overlooked symptom in gastroparesis Am J Gastroenterol 1999 94 1029 33
6. Talley NJ Vakil NB Moayyedi P American Gastroenterological Association technical review on the evaluation of dyspepsia Gastroenterology 2005 129 1756 80
7. Horowitz M Harding PE Maddox AF et al. Gastric and oesophageal emptying in insulin-dependent diabetes mellitus J Gastroenterol Hepatol 1986 1 97 113
8. Jones KL Russo A Stevens JE Wishart JM Berry MK Horowitz M Predictors of delayed gastric emptying in diabetes Diabetes Care 2001 24 1264 9
9. Stanghellini V Tosetti C Paternico A et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia Gastroenterology 1996 110 1036 42
10. Sarnelli G Caenepeel P Geypens B Janssens J Tack J Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia Am J Gastroenterol 2003 98 783 8
11. Delgado-Aros S Camilleri M Cremonini F Ferber I Stephens D Burton DD Contributions of gastric volumes and gastric emptying to meals size and postmeal symptoms in functional dyspepsia Gastroenterology 2004 127 1685 94
12. Mearin F Camilleri M Malagelada JR Pyloric dysfunction in diabetics with recurrent nausea and vomiting Gastroenterology 1986 90 1919 25
13. Camilleri M Brown ML Malagelada JR Relationship between impaired gastric emptying and abnormal gastrointestinal motility Gastroenterology 1986 91 94 9
14. Karamanolis G Arts J Caenepeel P Verbeke K Janssens J Tack J Determinants of symptom pattern in idiopathic gastroparesis: gastric emptying or proximal stomach dysfunction Gastroenterology 2005 128 A547 (abstract)
15. Samsom M Salet GAM Roelofs JMM Akkermans LM Vanberge-Henegouwen GP Smout AJ Compliance of the proximal stomach and dyspeptic symptoms in patients with type 1 diabetes mellitus Dig Dis Sci 1995 40 2037 42
16. Bredenoord AJ Chial HJ Camilleri M Mullan BP Murray JA Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms Clin Gastroenterol Hepatol 2003 1 264 72
17. Revicki DA Rentz AM Dubois D et al. Development and validation of a patient-assessed gastroparesis symptoms severity measure: the Gastroparesis Cardinal Symptom Index Aliment Pharmacol Ther 2003 18 141 50
18. Parrish CR Yoshida C Nutrition intervention for the patient with gastroparesis: an update Pract Gastroenterol 2005 29 29 35
19. Emerson AP Foods high in fiber and phytobezoar formation J Am Diet Assoc 1987 87 1675 7
20. Sturm A Holtmann G Goebell H Gerken G Prokinetics in patients with gastroparesis: a systematic analysis Digestion 1999 60 422 7
21. McCallum TW Ricci DA Rakatansky H et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis Diabetes Care 1983 6 463 7
22. Ricci D Saltzman M Meyer C Callachan C McCallum RW Effect of metoclopramide in diabetic gastroparesis J Clin Gastroenterol 1985 7 25 32
23. Snape WJ Battle WM Schwartz SS Braunstein SN Goldstein HA Alavi A Metoclopramide to treat gastroparesis due to diabetes mellitus Ann Intern Med 1982 96 444 6
24. Chen JDZ Pan J McCallum RW Clinical significance of gastric myoelectrical dysrhythmias Dig Dis 1995 13 275 90
25. McCallum RW Valenzuela G Polepalle S Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics J Pharmacol Exp Ther 1991 258 136 42
26. Ganzini L Casey DE Hoffman WF McCall AL The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders Arch Intern Med 1993 153 1469 75
27. Shaffer D Butterfield M Pamer C Mackey AC Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride J Am Pharm Assoc 2004 44 661 5
28. Patterson D Abell T Rothstein R Koch K Barnett J A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis Am J Gastroenterol 1999 94 1230 4
29. Silvers D Kipnes M Broadstone V et al. Domperidone in the management of symptoms of diabetic gastroparesis; efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial Clin Ther 1998 20 438 53
30. Koch KL Stern RM Stewart WR Vasey MW Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment Am J Gastroenterol 1989 84 1069 75
31. Soykan I Lin Z Jones S Chen J McCallum RW Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease Mov Disord 1997 12 952 7
32. Sawant P Das HS Desai N Kalokhe S Patil S Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia J Assoc Physicians India 2004 52 626 8
33. Basque J-R Noritake M Mizogami H Katsura Y Efficacy of itopride hydrochloride on gastric emptying in patients with diabetic gastroparesis Gastroenterology 2005 128 A156 (abstract)
34. Farrugia G Macielaq M Peeters TL Sarr MG Galdes A Szurszewski JH Motilin and OHM-11526 activate a calcium current in human and canine jejunal circular smooth muscle Am J Physiol 1997 36 G404 12
35. Weber FH Richard RE McCallum RW Erythromycin: a motilin agonist and gastrointestinal prokinetic agent Am J Gastroenterol 1993 88 485 90
36. Moshiree B Gupta V Verne GN Toskes PP Azithromycin: a new therapy for gastroparesis Gastroenterology 2005 128 A547 (abstract)
37. Kendall BJ Chakravarti A Kendall E Soykan L McCallum RW The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy antrectomy gastroparesis Aliment Pharmacol Ther 1997 11 381 5
38. Parkman HP Pagano AP Vozzelli M Ryan JP The gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in the rabbit stomach Am J Physiol 1995 269 G418 26
39. Parkman HP Pagano AP Ryan JP Erythromycin inhibits pyloric muscle by releasing nitric oxide and VIP through neuronal motilin receptors Gastroenterology 1996 111 682 90
40. Coulie B Tack J Peeters T Janssens J Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans Gut 1998 43 395 400
41. Maganti K Onyemere K Jones MP Oral erythromycin and symptomatic relief of gastroparesis: a systematic review Am J Gastroenterol 2003 98 259 63
42. Richards RD Davenport K McCallum RW The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin Am J Gastroenterol 1993 88 203 7
43. Ray WA Murray KT Meredith S Narasimhulu SS Hall K Stein CM Oral erythromycin and the risk of sudden death from cardiac causes N Engl J Med 2004 351 1089 96
44. Talley NJ Verlinden M Snape W et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying. A randomized double-blind placebo controlled trial Aliment Pharmacol Ther 2000 14 1653 6
45. Talley NJ Verlinden M Geenen DJ et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomized, double-blind, placebo controlled trial Gut 2001 49 395 401
46. McCallum RW Rogel R Fang JC Altman RS Faichney JD Goldstein BJ Mitemacil fumarate (GM-611) provided symptomatic relief of diabetic gastroparesis, especially in type I diabetics: results of a 12-week, multi-center, double-blind, placebo-controlled, randomized phase 2b study Gastroenterology 2005 128 A467 (abstract)
47. Murray CD Martin NM Patterson M et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double-blind, placebo-controlled, cross-over study Gut 2005 54 1693 8
48. Tack J Depoortere I Bisschops R Verbeke K Janssens J Peeters T Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis Aliment Pharmacol Ther 2005 22 847 53
49. Fraser RJ Horowitz M Maddox AF Dent J Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis - effects of cisapride Gut 1994 35 172 8
50. Braden B Enghofer M Schaub M Usadel KH Caspary WJ Lembcke B Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control Aliment Pharmacol Ther 2002 16 1341 6
51. Abell TL Camilleri M DiMagno EP Hench VS Zinsmeister AR Malagelada JR Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility Dig Dis Sci 1991 36 616 20
52. Jones MP Access options for withdrawn motility-modifying agents Am J Gastroenterol 2002 97 2184 8
53. Prather CM Camilleri M Zinsmeister AR McKinzie S Thomforde G Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome Gastroenterology 2000 118 463 8
54. 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects Aliment Pharmacol Ther 2001 15 1745 51
55. Tougas G Chen Y Luo D Salter J D'Elia T Earnest DL Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms Gastroenterology 2003 124 A54 (abstract)
56. Morganroth J Ruegg PC Dunger-Baldauf C Appel-Dingemanse S Bliesath H Lefkowitz M Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects Am J Gastroenterol 2002 97 2321 7
57. Kanaizumi T Nakano H Matsui Y et al. Prokinetic effect of AS-4370 on gastric emptying in healthy adults Eur J Clin Pharmacol 1991 41 335 7
58. Asakawa H Hayashi I Fukui T Tokunaga K Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy Diabetes Res Clin Pract 2003 61 175 82
59. Potet F Bouyssou T Escande D Baro I Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-a-gogo K(+) channel J Pharmacol Exp Ther 2001 299 1007 12
60. Malagelada JR Rees WD Mazzotta LJ Go VL Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol Gastroenterology 1980 78 286 93
61. McCallum RW Fink SM Lerner E Berkowitz DM Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients Gastroenterology 1983 84 1573 7
62. Parkman HP Trate DM Knight LC Brown KL Maurer AH Fisher RS Cholinergic effects on human gastric motility Gut 1999 45 346 54
63. Kishibayashi N Karasawa A Effects of KW-5092 on antroduodenal coordination and gastric emptying in guinea pigs J Pharm Pharmacol 1998 50 1045 50
64. Ueki S Seiki M Yoneta T et al. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats J Pharmacol Exp Ther 1003 264 152 7
65. McCallum R Zarling E Goetsch CA et al. Nizatidine controlled release has gastric prokinetic effects in patients with gastroesophageal reflux disease (GERD) Gastroenterology 2004 126 Suppl. 2 A-335
66. Rosa-e-Silva L Troncon LE Oliveira RB Iazigi N Gallo L Jr. Foss MC Treatment of diabetic gastroparesis with oral clonidine Aliment Pharmacol Ther 1995 9 179 83
67. Huilgol V Evans J Hellman RS Soergel KH Acute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controls Aliment Pharmacol Ther 2002 16 945 50
68. Lossos IS Mevorach D Oren R Thiethylperazine treatment of gastroparesis diabeticorum Ann Pharmacother 1992 26 1016
69. Kranke P Morin AM Roewer N et al. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review Anesth Analg 2002 95 133 43
70. Hurwitz A Robinson RG Herrin WF Christie J Oral anticholinergics and gastric emptying Clin Pharmacol Ther 1982 31 168 74
71. Jaup BH Dotevall G The effect of pirenzipine and L-hyoscyamine on gastric emptying and salivary secretion in healthy volunteers Scand J Gastroenterol 1981 16 769 73
72. Kranke P Morin AM Roewer N Eberhart LH Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials Acta Anaesthesiol Scand 2002 46 238 44
73. Kothari SN Boyd WC Bottcher ML Lambert PJ Antiemetic efficacy of prophylactic dimenhydrinate vs. ondansetron: a randomized, prospective trial in patients undergoing laparoscopic cholecystectomy Surg Endosc 2000 14 926 9
74. Stewart JJ Wood MJ Wood CD Mims ME Effects of motion sickness and antimotion sickness drugs on gastric function J Clin Pharmacol 1994 34 635 43
75. El-Gammal A Rashed HM Taylor J Werkman R Abell TL Long term ondansetron therapy is beneficial in patients with chronic nausea and vomiting Gastroenterology 2000 118 A1170 (abstract)
76. Netzer P Gaia C Lourens ST et al. Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers Aliment Pharmacol Ther 2002 16 119 27
77. Nielsen OH Hvid-Jacobsen K Lund P Langoholz E Gastric emptying and subjective symptoms of nausea: lack of effect of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome Digestion 1990 46 89 96
78. 3 receptor antagonist ICS 205-930 on fat-delayed gastric emptying and antral motor activity Br J Clin Pharmacol 1990 30 41 8
79. McCallum RW Soykan I Sridhar KR et al. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study Aliment Pharmacol Ther 1999 13 77 80
80. Adelhoj B Petring OU Brynnum J et al. Effect of diazepam on drug absorption and gastric emptying in man Br J Anaesth 1985 57 1107 9
81. Dando TM Perry CM Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting Drugs 2004 64 777 94
82. 1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery Br J Anaesth 1999 82 274 6
83. Prakash C Lustman PJ Freedland KE Clouse RE Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients Dig Dis Sci 1998 43 1951 6
84. Sawhney MS Prakash C Lustman PJ Clouse RE Tricyclic antidepressants for persistent or recurrent vomiting in diabetic patients Gastroenterology 2001 120 A243 (abstract)
85. Gupta YK Sharma M Reversal of pyrogallol-induced delay in gastric emptying in rats by ginger (Zingiber officinale) Methods Find Exp Clin Pharmacol 2001 23 501 3
86. Gonlachanvit S Chen YH Hasler WL et al. Ginger reduces hyperglycemia-evoked gastric dysrhythmias in healthy humans: possible role of endogenous prostaglandins J Pharmacol Exp Ther 2003 307 1098 103
87. Roscoe JA Morrow GR Hickok JT et al. The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting J Pain Symptom Manage 2003 26 731 42
88. Wang L Clinical observation on acupuncture treatment in 35 cases of diabetic gastroparesis J Tradit Chin Med 2004 24 163 5
89. Rathmann W Enck P Frieling T Gries FA Visceral afferent neuropathy in diabetic gastroparesis Diabetes Care 1991 14 1086 9
90. Hasler WL Soudah HC Dulai G Owyang C Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins Gastroenterology 1995 108 727 36
91. Pimentel M Sam C Lin HC Indomethacin improves symptoms and electrogastrographic findings in patients with gastric dysrhythmias Neurogastroenterol Motil 2001 13 422 (abstract)
92. Simonian HP Parkman HP Effect of prostaglandin inhibition with ketorolac on gastric activity and dyspeptic symptoms in patients with dyspeptic symptoms Am J Gastroenterol 2003 98 Suppl. S58
93. Gorelick AB Koshy SS Hooper FG et al. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans Am J Physiol 1998 2756 G460 6
94. Goldstein DJ Lu Y Detke MJ Lee TC Iyengar S Duloxetine vs. placebo in patients with painful diabetic neuropathy Pain 2005 116 109 18
95. Chial HJ Camilleri M Burton D Thomforde G Olden KW Stephens D Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health Am J Physiol Gastrointest Liver Physiol 2003 284 G130 7
96. Gorard DA Libby GW Farthing MJ 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake Gut 1994 35 496 500
97. Duby JJ Campbell RK Setter SM White JR Rasmussen KA Diabetic neuropathy: an intensive review Am J Health Syst Pharm 2004 61 160 73
98. Carroll DG Kline KM Malnar KF Role of topiramate for the treatment of painful diabetic peripheral neuropathy Pharmacotherapy 2004 24 1186 93
99. Malcom A Camilleri M Kost L et al. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function Aliment Pharmcol Ther 2000 14 783 93
100. Maurer AH Krevsky B Knight LC Brown K Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy J Nucl Med 1996 37 818 22
101. Mercadante S Casuccio A Fulfaro F et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study J Clin Oncol 2001 19 2898 904
102. Tawfik MO Bryuzgin V Kourteva G FEN-INT-20 Study Group Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain Curr Med Res Opin 2004 20 259 67
103. Liu M Wittbrodt E Low-dose oral naloxone reverses opioid-induced constipation and analgesia J Pain Symptom Manage 2002 23 48 53
104. Foss JF A review of the potential role of methylnaltrexone in opioid bowel dysfunction Am J Surg 2001 182 19S 26S
105. Gonenne J Camilleri M Ferber I et al. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study Clin Gastroenterol Hepatol 2005 3 784 91
106. Talley NJ Weaver AL Zinmeister AR Impact of functional dyspepsia on quality of life Dig Dis Sci 1995 40 584 9
107. Cutts TF Abell TL Karas JG Kuns J Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia Dig Dis Sci 1996 41 1369 78
108. Clouse RE Lustman PJ Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy Am J Gastroenterol 1989 84 868 72
109. Drossman DA Talley NJ Leserman J Olden KW Barriero MA Sexual and physical abuse in gastrointestinal illness. Review and recommendations Ann Intern Med 1995 123 782 94
110. Cutts TF Luo J Starkebaum W Rashid H Abell TL Gastric electrical stimulation is superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term healthcare benefits Neurogastroenterol Motil 2005 17 35 43
111. Wagner EH Glasgow RE Davis C et al. Quality improvement in chronic illness care: a collaborative approach J Jt Comm Health Care Qual 2001 27 63 80
112. Rashed H Cutts T Luo J et al. Predictors of response to a behavioral treatment in patients with chronic gastric motility disorders Dig Dis Sci 2002 47 1020 6
113. Horowitz M Edelbroek M Fraser R Maddox A Wishart J Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment Scand J Gastroenterol 1991 26 673 84
114. Bytzer P Talley NJ Leemon M Young LJ Jones MP Horowitz M Prevalence of gastrointestinal symptoms associated with diabetes mellitus Arch Intern Med 2001 161 1989 96
115. Maleki D Locke GR III. Camilleri M et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community Arch Intern Med 2000 160 2808 16
116. Ziegler D Schadewaldt P Pour Mirza A et al. [13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function Diabetologia 1996 39 823 30
117. Talley NJ Diabetic gastropathy and prokinetics Am J Gastroenterol 2003 98 274 1
118. Fraser RJ Horowitz M Maddox AF Harding PE Chatterton BE Dent J Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus Diabetologia 1990 33 675 80
119. Oster-Jorgensen E Pedersen SA Larsen ML The influence of induced hyperglycaemia on gastric emptying rate in healthy humans Scand J Clin Lab Invest 1990 50 831 6
120. Jebbink RJ Samsom M Bruijs PP et al. Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus Gastroenterology 1994 107 1390 7
121. Frank JW Saslow SB Camilleri M Thomforde GM Dinneen S Rizza RA Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus Gastroenterology 1995 109 755 65
122. Barnett JL Owyang C Serum glucose concentration as a modulator of interdigestive gastric motility Gastroenterology 1988 94 739 44
123. Hasler WL Soudah HC Kulai G Owyang C Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins Gastroenterology 1995 108 727 36
124. Jones KL Horowitz M Berry M Wishart JM Guha S Blood glucose concentration influences postprandial fullness in IDDM Diabetes Care 1997 20 1141 6
125. Petrakis IE Chalkiadakis G Vrachassotakis N Sciacca V Vassilakis SJ Xynos E Induced-hyperglycemia attenuates erythromycin-induced acceleration of hypertonic liquid-phase gastric emptying in type I diabetic patients Dig Dis Sci 1999 17 241 7
126. Jones KL Berry M Kong MF Kwiatek MA Samsom M Horowitz M Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects Diabetes Care 1999 22 339 44
127. Gentilcore D O'Donovan D Jones KL Horowitz M Nutrition therapy for diabetic gastroparesis Curr Diab Rep 2003 35 418 26
128. Lehmann R Honegger RA Feinle C Freid M Spinas GA Schwizer W Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes and gastroparesis, a pilot study with cisapride as a model drug Exp Clin Endocrinol Diabetes 2003 111 255 61
129. Riddle MC Rosenstock J Gerich J Insulin Glargine 4002 Study Investigators The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 2003 26 3080 6
130. Shopbell JM Hopkins B Shronts EP Nutrition screening and assessment In Gottschlich M ed The Science and Practice of Nutrition Support: A Case-based Core Curriculum Dubuque Kendall/Hunt 2001 119 130
131. Parrish CR Krenitsky J McCray S University of Virginia Health System Nutrition Support Traineeship Syllabus 2003 Available at: (accessed 25 January 2006) q8
132. McCray S Walker S Parrish CR Much ado about refeeding Pract Gastroenterol 2005 29 26 8
133. Gupta P Rao SS Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report Gastrointest Endosc 2002 56 770 2
134. Lacy BE Crowell MD Schettler-Duncan A Mathis C Pasricha PJ The treatment of diabetic gastroparesis with botulinum toxin injection into the pylorus Diabetes Care 2004 27 2341 7
135. Lacy BE Zayat EN Crowell MD Schuster MM Botulinum toxin for the treatment of gastroparesis: a preliminary report Am J Gastroenterol 2002 97 1548 52
136. Miller LS Szych GA Kantor SB et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle Am J Gastroenterol 2002 97 1653 60
137. Ezzeddine D Jit R Katz N Gopalswamy N Bhutani MS Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis Gastrointest Endosc 2002 55 920 3
138. Arts J Van Gool S Caenepeel P Janssens J Tack J Effect of intrapyloric injection of botulinum toxin on gastric emptying and meal-related symptoms in gastroparesis Gastroenterology 2003 124 A53 (abstract)
139. Bromer MQ Friedenberg F Miller LS Fisher RS Swartz K Parkman HP Endoscopic pyloric injection of botulinum toxin A for treatment of refractory gastroparesis Gastrointest Endosc 2005 61 833 9
140. Coleski R Hasler W Clinical and gastric functional predictors of symptom response to pyloric injection of botulinum toxin in patients with gastroparesis Neurogastroenterol Motil 2005 17 628 (abstract) q9
141. Arts J Caenepeel P Degreef T et al. Randomized double-blind cross-over study evaluation the effect of intrapyloric injection of botulinum toxin on gastric emptying and symptoms in patients with gastroparesis Gastroenterology 2005 128 A81 (abstract)
142. Kim CH Nelson DK Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis Gastrointest Endosc 1998 47 67 70
143. Jones MP Maganti K A systematic review of surgical therapy for gastroparesis Am J Gastroenterol 2003 98 2122 9
144. McCallum RW Chen JDZ Lin Z Schirmer BD Williams RD Ross RA Gastric pacing improves emptying and symptoms in patients with gastroparesis Gastroenterology 1998 114 456 61
145. Abell T Custem EV Abrahamsson H Gastric electrical stimulation in intractable symptomatic gastroparesis Digestion 2002 66 204 21
146. Abell T McCallum R Hocking M et al. Gastric electrical stimulation for medically refractory gastroparesis Gastroenterology 2003 125 421 8
147. Abell T Lou J Tabaa M Batista O Malinowski S Al-Juburi A Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow up J Parenter Enteral Nutr 2003 98 277 81
148. Lin Z Forster J Sarosiek I McCallum RW Treatment of gastroparesis by high-frequency gastric electrical stimulation Diabetes Care 2004 27 1071 6
149. Lin Z McElhinney C Sarosiek I Forster J McCallum R Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations Dig Dis Sci 2005 50 1328 34
150. Abell T Al-Juburi A Bashed H Mirocha A 13 years, 214 patients and over 5000 patient months: a long term report on gastric electric stimulation Gastroenterology 2005 128 4 Suppl. 2 A282 (abstract)
151. Oubre B Luo J Al-Juburi A Voeller G Familoni B Abell TL Pilot study on gastric electric stimulation on surgery-associated gastroparesis: long-term outcome South Med J 2005 98 693 7
152. McCallum R Lin Z Wetzel P Sarosiek I Forster J Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis Clin Gastroenterol Hepatol 2005 3 49 54
153. Ayinala S Batista O Goyal A et al. Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis Gastrointest Endosc 2005 61 455 61
154. Lin Z Cocjin J Sarosiek I Roeser K McCallum RW Influence of high-frequency electrical stimulation on gastric electrical activity, autonomic function and symptoms in gastroparetic patients Neurogastroenterol Motil 2005 17 480 1
155. Tack J Coulie B Van Custem E et al. The influence of gastric electrical stimulation on proximal gastric motor and sensory function in severe idiopathic gastroparesis Gastroenterology 1999 116 G4733 (abstract)
156. Cocjin J Lin Z Scoggan R Sarosiek I McCallum RW Effects of high-frequency low-energy gastric electrical stimulation (Enterra device) on gastric distention and tone in gastroparetic patients Gastroenterology 2005 128 A136 (abstract)
157. McCallum RW Dusing R McMillin C et al. Fluoro-deoxyglucose (FDG) positron emission tomography (PET) in gastroparetic patients before and during gastric electrical stimulation (GES) Gastroenterolgy 2005 128 A622 (abstract)
158. Hasler W Nonoperative management of patients with gastroparesis referred for gastric electrical stimulator implantation Neurogastroenterol Motil 2005 17 480 (abstract)
159. Skole KS Panganamamula KV Bromer MQ Meilahn JE Fisher RS Parkman HP Efficacy of gastric electric stimulation for gastroparesis refractory to medical therapy Am J Gastroenterol 2002 97 S48 (abstract)
160. Watkins PJ Buxton-Thomas MS Howard ER Long-term outcome after gastrectomy for intractable diabetic gastroparesis Diabet Med 2003 20 58 63
161. Karlstrom L Kelly KA Roux-Y gastrectomy for chronic gastric atony Am J Surg 1989 157 44 9
162. McCallum RW Polepalle SC Schirmer B Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease Dig Dis Sci 1991 36 1556 61
163. Eckhauser RE Conrad M Knol JA Mulholland MW Colletti LM Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome Am Surg 1998 64 711 7
164. Forstner-Barthell AW Murr MM Nitecki S et al. Near-total completion gastrectomy for severe postvagotomy gastric stasis J Gastrointest Surg 1999 3 15 21
165. Kennedy WR Navarro X Goetz FC Sutherland DE Najarian JS Effects of pancreatic transplantation on diabetic neuropathy N Engl J Med 1990 322 1031 7
166. Murat A Pouliquen B Cantarovich D et al. Gastric emptying improvement after simultaneous segmental pancreas and kidney transplantation Transplant Proc 1992 24 855
167. Hathaway DK Abell T Cardoso S Hartwig MS el Gebely S Gaber AO Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life Transplantation 1994 57 816 22